-
Something wrong with this record ?
Iron overload reduces synthesis and elimination of bile acids in rat liver
A. Prasnicka, H. Lastuvkova, F. Alaei Faradonbeh, J. Cermanova, M. Hroch, J. Mokry, E. Dolezelova, P. Pavek, K. Zizalova, L. Vitek, P. Nachtigal, S. Micuda,
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
Nature Open Access
from 2011-12-01
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
Springer Nature OA/Free Journals
from 2011-12-01
- MeSH
- Biomarkers MeSH
- Cholesterol metabolism MeSH
- Gene Expression MeSH
- Liver metabolism pathology MeSH
- Rats MeSH
- RNA, Messenger genetics metabolism MeSH
- Disease Models, Animal MeSH
- Oxidative Stress MeSH
- Iron Overload etiology metabolism pathology MeSH
- Bile Acids and Salts metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Excessive iron accumulation in the liver, which accompanies certain genetic or metabolic diseases, impairs bile acids (BA) synthesis, but the influence of iron on the complex process of BA homeostasis is unknown. Thus, we evaluated the effect of iron overload (IO) on BA turnover in rats. Compared with control rats, IO (8 intraperitoneal doses of 100 mg/kg every other day) significantly decreased bile flow as a consequence of decreased biliary BA secretion. This decrease was associated with reduced expression of Cyp7a1, the rate limiting enzyme in the conversion of cholesterol to BA, and decreased expression of Bsep, the transporter responsible for BA efflux into bile. However, IO did not change net BA content in faeces in response to increased intestinal conversion of BA into hyodeoxycholic acid. In addition, IO increased plasma cholesterol concentrations, which corresponded with reduced Cyp7a1 expression and increased expression of Hmgcr, the rate-limiting enzyme in de novo cholesterol synthesis. In summary, this study describes the mechanisms impairing synthesis, biliary secretion and intestinal processing of BA during IO. Altered elimination pathways for BA and cholesterol may interfere with the pathophysiology of liver damage accompanying liver diseases with excessive iron deposition.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028880
- 003
- CZ-PrNML
- 005
- 20210114155255.0
- 007
- ta
- 008
- 210105s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-019-46150-7 $2 doi
- 035 __
- $a (PubMed)31278332
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Prasnicka, Alena $u Department of Pharmacology, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic. Department of Biological and Medical Sciences, Charles University, Faculty of Pharmacy in Hradec Kralove, Hradec Kralove, Czech Republic.
- 245 10
- $a Iron overload reduces synthesis and elimination of bile acids in rat liver / $c A. Prasnicka, H. Lastuvkova, F. Alaei Faradonbeh, J. Cermanova, M. Hroch, J. Mokry, E. Dolezelova, P. Pavek, K. Zizalova, L. Vitek, P. Nachtigal, S. Micuda,
- 520 9_
- $a Excessive iron accumulation in the liver, which accompanies certain genetic or metabolic diseases, impairs bile acids (BA) synthesis, but the influence of iron on the complex process of BA homeostasis is unknown. Thus, we evaluated the effect of iron overload (IO) on BA turnover in rats. Compared with control rats, IO (8 intraperitoneal doses of 100 mg/kg every other day) significantly decreased bile flow as a consequence of decreased biliary BA secretion. This decrease was associated with reduced expression of Cyp7a1, the rate limiting enzyme in the conversion of cholesterol to BA, and decreased expression of Bsep, the transporter responsible for BA efflux into bile. However, IO did not change net BA content in faeces in response to increased intestinal conversion of BA into hyodeoxycholic acid. In addition, IO increased plasma cholesterol concentrations, which corresponded with reduced Cyp7a1 expression and increased expression of Hmgcr, the rate-limiting enzyme in de novo cholesterol synthesis. In summary, this study describes the mechanisms impairing synthesis, biliary secretion and intestinal processing of BA during IO. Altered elimination pathways for BA and cholesterol may interfere with the pathophysiology of liver damage accompanying liver diseases with excessive iron deposition.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a žlučové kyseliny a soli $x metabolismus $7 D001647
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a cholesterol $x metabolismus $7 D002784
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a přetížení železem $x etiologie $x metabolismus $x patologie $7 D019190
- 650 _2
- $a játra $x metabolismus $x patologie $7 D008099
- 650 _2
- $a oxidační stres $7 D018384
- 650 _2
- $a messenger RNA $x genetika $x metabolismus $7 D012333
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Lastuvkova, Hana $u Department of Pharmacology, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
- 700 1_
- $a Alaei Faradonbeh, Fatemeh $u Department of Pharmacology, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
- 700 1_
- $a Cermanova, Jolana $u Department of Pharmacology, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
- 700 1_
- $a Hroch, Milos $u Department of Medical Biochemistry, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
- 700 1_
- $a Mokry, Jaroslav $u Department of Histology and Embryology, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
- 700 1_
- $a Dolezelova, Eva $u Department of Biological and Medical Sciences, Charles University, Faculty of Pharmacy in Hradec Kralove, Hradec Kralove, Czech Republic.
- 700 1_
- $a Pavek, Petr $u Department of Pharmacology and Toxicology, Charles University, Faculty of Pharmacy in Hradec Kralove, Hradec Kralove, Czech Republic.
- 700 1_
- $a Zizalova, Katerina $u Department of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Vitek, Libor $u Department of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Nachtigal, Petr $u Department of Biological and Medical Sciences, Charles University, Faculty of Pharmacy in Hradec Kralove, Hradec Kralove, Czech Republic.
- 700 1_
- $a Micuda, Stanislav $u Department of Pharmacology, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic. micuda@lfhk.cuni.cz.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 9, č. 1 (2019), s. 9780
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31278332 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114155253 $b ABA008
- 999 __
- $a ok $b bmc $g 1609215 $s 1120060
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 9 $c 1 $d 9780 $e 20190705 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20210105
